1. National Cancer Institute: Surveillance Epidemiology, and End Results Program: SEER stat fact sheets-all sites.
Google Scholar2. Slamon, DJ, Clark, GM, Wong, SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182.
Google Scholar | Crossref | Medline | ISI3. Diéras, V, Miles, D, Verma, S, et al. Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. Lancet Oncol 2017 Jun; 18: 732–742. Epub 2017 May 16.
Google Scholar | Crossref | Medline4. Krop, IE, LoRusso, P, Miller, KD, et al. A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine. J Clin Oncol 2012; 30: 3234–3241.
Google Scholar | Crossref | Medline | ISI5. Beeram, M, Krop, IE, Burris, HA, et al. A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer. Cancer 2012; 118: 5733–5740.
Google Scholar | Crossref | Medline | ISI6. Burris, HA, Rugo, HS, Vukelja, SJ, et al. Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy. J Clin Oncol 2011; 29: 398–405.
Google Scholar | Crossref | Medline | ISI7. Ruiz-Rivero, J, Horcajada-Reales, C, Tardío, JC, et al. Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment. An Bras Dermatol 2018 Nov/Dec; 93: 938–939.
Google Scholar | Crossref | Medline8. Loufrani, L, Henrion, D. Role of the cytoskeleton in flow (shear stress)-induced dilation and remodeling in resistance arteries. Med Biol Eng Comput 2008; 46: 451–460.
Google Scholar | Crossref | Medline9. Fernandez-L, A, Sanz-Rodriguez, F, Blanco, FJ, et al. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-signaling pathway. Clin Med & Res 2006; 4: 66–78.
Google Scholar | Crossref | Medline